Maven Securities’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,500
Closed -$9.56M 546
2025
Q4
$9.56M Buy
+16,500
New +$9.33M 0.21% 115
2025
Q3
Sell
-2,500
Closed -$1.01M 804
2025
Q2
$1.01M Buy
+2,500
New +$1.05M 0.02% 441
2025
Q1
Sell
-4,100
Closed -$2.13M 977
2024
Q4
$2.13M Sell
4,100
-4,300
-51% -$2.36M 0.05% 269
2024
Q3
$5.2M Buy
8,400
+200
+2% +$118K 0.1% 168
2024
Q2
$4.53M Buy
+8,200
New +$4.7M 0.1% 209
2024
Q1
Sell
-5,700
Closed -$3.03M 936
2023
Q4
$3.03M Sell
5,700
-9,900
-63% -$4.79M 0.06% 226
2023
Q3
$7.9M Buy
15,600
+10,600
+212% +$5.65M 0.09% 124
2023
Q2
$2.61M Buy
5,000
+4,100
+456% +$2.21M 0.04% 234
2023
Q1
$519K Buy
+900
New +$507K 0.01% 646
2021
Q4
Sell
-1,400
Closed -$800K 1146
2021
Q3
$800K Buy
+1,400
New +$768K 0.03% 518
2020
Q1
Sell
-2,000
Closed -$649K 435
2019
Q4
$649K Buy
+2,000
New +$606K 0.06% 226

Other funds holding TMO

Maven Securities's TMO Position: Q1 2026 in Review

Maven Securities opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 24,800 shares worth $12.2M. The stake represents 0.23% of the portfolio and ranks #89 among its holdings. This is a return to the name: Maven Securities previously reported a position in TMO as recently as Q4 2024.

Maven Securities first reported a position in TMO in Q4 2020 and has held it in 10 quarters since. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Maven Securities held 24,800 shares of Thermo Fisher Scientific worth $12.2M as of Q1 2026.
  • Thermo Fisher Scientific was a new Maven Securities position in Q1 2026.
  • Thermo Fisher Scientific made up 0.23% of Maven Securities's portfolio in Q1 2026, its #89 holding.
  • Maven Securities first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 10 quarters since.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Maven Securities's 13F filing for Q1 2026, filed 15 May 2026.